Hermetica Superfood Encyclopedia
The Short Answer
Afzelia africana contains flavonoids, phenolics, alkaloids, terpenoids, and steroids that exert antioxidant activity through hydrogen atom and electron donation (DPPH IC50 as low as 1.70±0.01 µg/mL), antimicrobial effects via bactericidal mechanisms (MBC 1.25–10.0 mg/mL), and antiplasmodial activity through disruption of Plasmodium falciparum metabolism (IC50 2.97 µg/mL crude methanol extract). The most consistently demonstrated preclinical benefit is antioxidant capacity, with ABTS radical scavenging reaching 54–93% and DPPH scavenging reaching 35–76% at concentrations of 0.01–1.0 mg/mL across bark fractions.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordAfzelia africana benefits
Apa-igbo — botanical close-up
Health Benefits
**Antioxidant Protection**
Bark fractions achieve ABTS radical scavenging of 54–93% and DPPH scavenging of 35–76% at 0.01–1.0 mg/mL, attributed to flavonoids and phenolics that donate hydrogen atoms or electrons to neutralize reactive oxygen species implicated in chronic disease.
**Antimicrobial Activity**
Bark fractions F1 and F4 demonstrate bactericidal action with minimum bactericidal concentrations (MBC) of 1.25–10.0 mg/mL against tested pathogens, and synergistic interactions have been identified via checkerboard fractional inhibitory concentration index (FICI) assays, supporting traditional use against infectious conditions including gonorrhea.
**Antiplasmodial Effects**: Crude methanol bark extract exhibits an IC50 of 2
97 µg/mL against Plasmodium falciparum 3D7 in vitro, with phenolics, alkaloids, steroids, and flavonoids credited with disrupting parasite metabolic processes relevant to malaria treatment.
**Nutritional Supplementation**: Seeds provide significant calcium (188
80±5.54 mg/100g), protein, carbohydrates, and fats, positioning them as a functional food supplement for addressing micronutrient gaps in human and livestock diets across sub-Saharan Africa.
**Anti-inflammatory Potential**
The presence of steroids, terpenoids, and flavonoids in roots, bark, and leaves suggests anti-inflammatory activity consistent with traditional use for conditions involving hernia and tissue inflammation, though direct mechanistic studies in this area remain limited.
**Phytochemical Richness Supporting Multiple Bioactivities**: GC-MS analysis of bark fractions detects 88–95 distinct secondary metabolites per fraction including anthraquinones, coumarins, glycosides, and alkaloids, indicating broad-spectrum pharmacological potential across infection, oxidative stress, and metabolic disease applications.
**Mineral and Micronutrient Delivery**: Leaves are rich in potassium (368
67±3.06 mg/100g), phosphorus, and vitamin C (12.69±1.02 mg/100g), while stems provide high dietary fiber (61.1±0.23%), collectively supporting cardiovascular, immune, and digestive health when consumed as part of traditional diets.
Origin & History
Natural habitat
Afzelia africana is a large deciduous tree native to the savanna woodlands and dry forests of West and Central Africa, distributed across countries including Nigeria, Ghana, Senegal, Cameroon, and the Democratic Republic of Congo. It thrives in well-drained lateritic soils at elevations up to 1,000 meters, tolerating seasonal drought and is commonly found in Guinea-Congolian and Sudanian vegetation zones. The tree is not widely cultivated commercially but is harvested from wild stands, with bark, seeds, leaves, stems, and roots all used in traditional medicine and local nutrition.
“Afzelia africana holds significant ethnobotanical importance across West and Central Africa, with the Igbo people of southeastern Nigeria employing the bark and other plant parts under the local name Apa-igbo to treat gonorrhea and hernia, representing a long-standing tradition of using the plant for urogenital and structural complaints. In broader West African ethnomedicine, the tree's bark has been used for malaria, various infectious diseases, and conditions associated with oxidative stress, consistent with the antiplasmodial and antioxidant activities now documented in laboratory research. Traditional preparation typically involves aqueous decoctions of bark or powdered seeds consumed orally, with specific formulations passed through generations of local healers and herbalists. The tree also holds cultural and economic significance as a source of heavy, durable timber used in construction and furniture, and its seeds serve as a food source in rural communities, reflecting its dual role as both a medicinal and nutritional resource in indigenous African knowledge systems.”Traditional Medicine
Scientific Research
Available evidence for Afzelia africana is entirely preclinical, comprising in vitro antimicrobial, antioxidant, antiplasmodial, and nutritional assays; no human clinical trials or animal pharmacokinetic studies have been published as of the current literature search. Antioxidant studies used standardized DPPH and ABTS radical scavenging assays with multiple bark fractions, producing quantified IC50 values (1.70±0.01 µg/mL stem bark DPPH), while antiplasmodial studies employed the SYBR Green I fluorescence assay against the chloroquine-sensitive P. falciparum 3D7 strain with IC50 of 2.97 µg/mL for crude methanol extract and 37.09±6.14 µg/mL for fraction 4. Antimicrobial data were generated via broth microdilution and checkerboard synergy assays, with MBC values of 1.25–10.0 mg/mL for active fractions, indicating bactericidal rather than merely bacteriostatic activity for F1 and F4 fractions. The overall evidence base is limited in translational relevance due to the absence of in vivo efficacy models, pharmacokinetic data, toxicity studies, and randomized controlled trials, placing confidence in therapeutic claims at a preliminary, hypothesis-generating level.
Preparation & Dosage
Traditional preparation
**Traditional Decoction (Bark)**
Dried bark is boiled in water and the decoction consumed orally; exact volumes and concentrations are not standardized in the ethnobotanical literature.
**Traditional Powder (Seeds/Bark)**
Dried seeds or bark are ground into powder and incorporated into food or mixed with water; used as nutritional supplement for humans and livestock.
**Methanol Extract (Research Grade)**
Laboratory preparations use 80–100% methanol extraction followed by column chromatography fractionation to isolate active fractions; research IC50 values of 1.21–2.97 µg/mL are not directly translatable to human doses.
**Effective In Vitro Concentration Range**
0 mg/mL in vitro; no human equivalent dose has been established
Antioxidant and antimicrobial activities have been demonstrated at 0.01–1..
**Standardization**
No commercial standardized extracts or defined marker compound percentages are currently available; GC-MS profiling of 88–95 metabolites per fraction has been proposed as a basis for future standardization.
**Timing and Duration**
No clinical data exist to guide dosing frequency or treatment duration; traditional use patterns vary by community and indication.
Nutritional Profile
Seeds represent the most nutritionally dense part of the plant, containing significant quantities of carbohydrates, protein, and fats along with calcium at 188.80±5.54 mg/100g and sodium at 11.63±0.40 mg/100g; phytate content is relatively low at 0.40±0.03%, suggesting reasonable mineral bioavailability. Leaves contribute potassium (368.67±3.06 mg/100g), phosphorus, and vitamin C (12.69±1.02 mg/100g), supporting electrolyte balance and antioxidant defense. Stems are characterized by exceptionally high crude fiber content (61.1±0.23%), relevant to digestive health and prebiotic potential. Phytochemical constituents across plant parts include flavonoids, phenolics, steroids (up to 0.49±0.01% in roots), terpenoids, alkaloids, glycosides, anthraquinones, and coumarins, with GC-MS identifying 88–95 secondary metabolites per bark fraction; bioavailability of these phytochemicals in humans has not been assessed through pharmacokinetic studies.
How It Works
Mechanism of Action
Flavonoids and phenolic compounds in Afzelia africana bark fractions scavenge free radicals by donating hydrogen atoms or electrons to unstable radical species, quenching DPPH and ABTS radicals in vitro and reducing oxidative damage to lipids, proteins, and DNA at IC50 values as low as 1.21–1.70 µg/mL for stem bark extracts. Antimicrobial bactericidal activity, demonstrated by low MBC values of 1.25–10.0 mg/mL for fractions F1 and F4, likely involves disruption of bacterial cell membrane integrity and inhibition of essential metabolic enzymes, consistent with the actions of terpenoids, alkaloids, and phenolics identified via GC-MS. Antiplasmodial effects against P. falciparum 3D7 (IC50 2.97 µg/mL, crude extract) are attributed to alkaloids and flavonoids interfering with heme detoxification in the parasite's digestive vacuole and disrupting mitochondrial electron transport, mechanisms shared with known antimalarial phytochemicals. Steroids predominant in roots (0.49±0.01%) may modulate inflammatory signaling pathways by interacting with steroid-responsive nuclear receptors, while coumarins and anthraquinones could contribute to genotoxic effects on microbial DNA, though formal molecular docking or pathway-level studies have not yet been conducted for this species.
Clinical Evidence
No human clinical trials investigating Afzelia africana for any indication have been identified in the published literature. All quantified efficacy data derive from cell-free radical scavenging assays, broth microdilution antimicrobial tests, and P. falciparum in vitro culture assays, none of which directly predict clinical outcomes in humans. Traditional ethnobotanical use by Igbo communities for gonorrhea and hernia, and broader West African use for malaria and infectious disease, provides a framework for research prioritization but does not constitute clinical evidence. Until controlled trials with human subjects are conducted measuring infection clearance, symptom resolution, or biomarker changes, clinical recommendations cannot be made with confidence.
Safety & Interactions
No formal toxicological studies, adverse event reports, or maximum tolerated dose data have been published for Afzelia africana in humans or standard animal models, leaving its safety profile incompletely characterized. Traditional use of seeds as a human and livestock food supplement implies reasonable tolerability at dietary quantities, and GC-MS profiling has been proposed as a foundation for future toxicity standardization, but this does not constitute a validated safety assessment. No documented drug interactions exist in the literature; however, the presence of anthraquinones (which can have laxative and potential genotoxic effects at high doses), alkaloids (which may interact with cytochrome P450 enzymes affecting drug metabolism), and potent antioxidant phenolics (which could theoretically interfere with oxidative mechanisms of certain chemotherapeutic agents) warrants caution when combining with pharmaceutical drugs. Use during pregnancy and lactation cannot be recommended due to the complete absence of relevant safety data, and individuals with known plant allergies or renal conditions should exercise caution given the uncharacterized alkaloid and phytate content.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Afzelia africanaApa-igboApa (Yoruba)Papao (Ghana)Lenke (Senegal)African mahogany bean
Frequently Asked Questions
What is Apa-igbo used for in traditional Igbo medicine?
In Igbo traditional medicine, Apa-igbo (Afzelia africana) is primarily used to treat gonorrhea and hernia, with bark preparations consumed as decoctions or powders. These uses are supported by preclinical evidence showing bactericidal activity with MBC values of 1.25–10.0 mg/mL for active bark fractions and anti-inflammatory potential from steroids and terpenoids, though no clinical trials have validated these applications in humans.
Does Afzelia africana have antimalarial properties?
Preclinical research shows that crude methanol bark extract of Afzelia africana inhibits Plasmodium falciparum 3D7 growth in vitro with an IC50 of 2.97 µg/mL, a value considered moderately potent by standard antiplasmodial screening criteria. Alkaloids, phenolics, flavonoids, and steroids identified in the extract are believed to disrupt parasite heme detoxification and mitochondrial function, but no in vivo animal studies or human clinical trials have confirmed antimalarial efficacy or safety.
What are the main bioactive compounds in Afzelia africana bark?
GC-MS analysis of Afzelia africana bark fractions identifies 88–95 secondary metabolites per fraction, with the major classes being flavonoids, phenolics, alkaloids, terpenoids, steroids, glycosides, anthraquinones, and coumarins. Flavonoids and phenolics are primarily responsible for the strong antioxidant activity (DPPH IC50 1.70±0.01 µg/mL; ABTS scavenging 54–93%), while alkaloids and steroids are implicated in antimicrobial and antiplasmodial effects.
Is Afzelia africana safe to consume?
No formal human toxicological studies have been conducted on Afzelia africana, so its complete safety profile is unknown. Seeds are traditionally consumed as food by humans and livestock in West Africa, suggesting tolerability at dietary amounts, but the presence of alkaloids and anthraquinones in bark extracts warrants caution at medicinal doses, and use during pregnancy or alongside pharmaceutical drugs cannot be considered safe without further research.
What nutritional value does Afzelia africana provide?
Afzelia africana seeds are nutritionally rich, providing notable calcium (188.80±5.54 mg/100g), protein, carbohydrates, and fats with relatively low antinutrient phytate (0.40±0.03%), while leaves supply high potassium (368.67±3.06 mg/100g) and vitamin C (12.69±1.02 mg/100g). Stems contain exceptionally high crude fiber (61.1±0.23%), supporting digestive health, making different plant parts complementary contributors to overall nutritional intake in communities where the plant is consumed.
How does Afzelia africana compare to other African herbs for antioxidant protection?
Afzelia africana bark demonstrates strong antioxidant capacity with ABTS radical scavenging of 54–93% and DPPH scavenging of 35–76%, performance comparable to many documented medicinal plants from the African continent. Its antioxidant potency is attributed to high concentrations of flavonoids and phenolic compounds that directly neutralize reactive oxygen species. This makes it competitive with other traditionally valued African antioxidant sources, though direct clinical comparison studies remain limited.
What is the difference between Afzelia africana bark and other plant parts in terms of bioactive content?
Afzelia africana bark is the most extensively studied and pharmacologically active part of the plant, containing concentrated flavonoids and phenolic compounds responsible for antimicrobial and antioxidant effects. Different bark fractions (F1, F4, etc.) show varying levels of bactericidal potency and radical scavenging ability depending on extraction methods. Other parts of the plant have not been as thoroughly evaluated for bioactive compound concentration or therapeutic efficacy.
What does current research reveal about Afzelia africana's antimicrobial effectiveness?
Research demonstrates that specific bark fractions of Afzelia africana exhibit bactericidal activity, with minimum bactericidal concentrations indicating potent antimicrobial potential against tested organisms. The antimicrobial effects are attributed to the plant's phenolic and flavonoid content, which can disrupt bacterial cell function. However, most studies are in vitro, and clinical efficacy in humans requires further investigation.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w apa-igbo-afzelia-africana curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
